Home>>Signaling Pathways>> TGF-β / Smad Signaling>> PKC>>Fasudil (HA-1077) HCl

Fasudil (HA-1077) HCl Sale

(Synonyms: 盐酸法舒地尔; HA-1077 Hydrochloride; AT-877 Hydrochloride) 目录号 : GC14289

Fasudil (HA-1077) HCl(法舒地尔;HA-1077;AT877)是一种非特异性RhoA/ROCK抑制剂,对ROCK1的Ki为0.33μM,IC50为0.158μM,对ROCK2和PKA、PKC、PKG的IC50分别为4.58μM、12.30μM、1.650μM。

Fasudil (HA-1077) HCl Chemical Structure

Cas No.:105628-07-7

规格 价格 库存 购买数量
10mM (in 1mL DMSO)
¥399.00
现货
200mg
¥525.00
现货
500mg
¥945.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

Description

Fasudil (HA-1077) HCl (HA-1077; AT877) is a non-specific RhoA/ROCK inhibitor with a Ki of 0.33μM and an IC50 of 0.158μM for ROCK1, and IC50 of 4.58μM, 12.30μM, and 1.650μM for ROCK2, PKA, PKC, and PKG, respectively[1]. The monomeric G protein RhoA and its activated target Rho kinase (ROCK) constitute the RhoA/ROCK signaling pathway, which has the function of inducing cytoskeletal reorganization, cell migration, and stress fiber formation, and also affects endothelial permeability, tissue compatibility, cell proliferation, and apoptosis[2, 3]. Fasudil (HA-1077) HCl is also an effective Ca2+ channel antagonist and vasodilator[4].

In vitro, Fasudil (HA-1077) HCl (0-30μM) treatment of human bladder cancer cell lines (5637 and UM-UC-3 cells) for 72h inhibited cell proliferation and migration in a dose-dependent manner, induced cell apoptosis, and significantly reduced the expression of ROCK-I and ROCK-II[5]. Fasudil (HA-1077) HCl (0.04, 0.2, 1μg/mL) pre-treated the co-culture system established by neutrophils and human pulmonary microvascular endothelial cells (HPMECs) for 30min, reduced neutrophil transendothelial cell migration, and inhibited neutrophil endothelial chemotaxis[6]. Fasudil (HA-1077) HCl (100μM) treatment of rat hepatic stellate cells and human hepatic stellate cell-derived TWNT-4 cells inhibited cell extension, stress fiber formation, and α-SMA expression, stimulated the production and transcription of matrix metalloproteinase-1 (MMP-1), and enhanced collagenase activity[7].

In vivo, Fasudil (HA-1077) HCl (10mg/kg) was intravenously administered to mice after myocardial ischemia/reperfusion injury, inhibiting c-Jun N-terminal kinase (JNK)-mediated apoptosis-inducing factor (AIF) translocation and reducing cardiomyocyte apoptosis during ischemia/reperfusion[8].

References:
[1] Chen M, Liu A, Ouyang Y, et al. Fasudil (HA-1077) HCl and its analogs: a new powerful weapon in the long war against central nervous system disorders?[J]. Expert opinion on investigational drugs, 2013, 22(4): 537-550.
[2] Crosas-Molist E, Samain R, Kohlhammer L, et al. Rho GTPase signaling in cancer progression and dissemination[J]. Physiological Reviews, 2022, 102(1): 455-510.
[3] Radeva M Y, Waschke J. Mind the gap: mechanisms regulating the endothelial barrier[J]. Acta physiologica, 2018, 222(1): e12860.
[4] Chen Y, Yuan T, Zhang H, et al. Fasudil (HA-1077) HCl evokes vasodilatation of rat mesenteric vascular bed via Ca2+ channels and Rho/ROCK pathway[J]. European journal of pharmacology, 2016, 788: 226-233.
[5] Abe H, Kamai T, Hayashi K, et al. The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells[J]. BMC cancer, 2014, 14: 1-12.
[6] Wang J, Xu J, Zhao X, et al. Fasudil (HA-1077) HCl inhibits neutrophil-endothelial cell interactions by regulating the expressions of GRP78 and BMPR2[J]. Experimental cell research, 2018, 365(1): 97-105.
[7] Fukushima M, Nakamuta M, Kohjima M, et al. Fasudil (HA-1077) HCl hydrochloride hydrate, a Rho‐kinase (ROCK) inhibitor, suppresses collagen production and enhances collagenase activity in hepatic stellate cells[J]. Liver international, 2005, 25(4): 829-838.
[8] Zhang J, Li X X, Bian H J, et al. Inhibition of the activity of Rho-kinase reduces cardiomyocyte apoptosis in heart ischemia/reperfusion via suppressing JNK-mediated AIF translocation[J]. Clinica Chimica Acta, 2009, 401(1-2): 76-80.

Fasudil (HA-1077) HCl(法舒地尔;HA-1077;AT877)是一种非特异性RhoA/ROCK抑制剂,对ROCK1的Ki为0.33μM,IC50为0.158μM,对ROCK2和PKA、PKC、PKG的IC50分别为4.58μM、12.30μM、1.650μM[1]。单体G蛋白RhoA及其激活靶点Rho激酶(ROCK)组成了RhoA/ROCK信号通路,该通路具有诱导细胞骨架重组、细胞迁移和应力纤维形成功能,还影响内皮通透性、组织相容性、细胞增殖、细胞凋亡等[2, 3]。Fasudil (HA-1077) HCl也是一种有效的Ca2+通道拮抗剂和血管扩张剂[4]

在体外,Fasudil (HA-1077) HCl(0-30μM)处理人膀胱癌细胞系(5637和UM-UC-3细胞)72h,均以剂量依赖性方式抑制了细胞增殖和迁移,诱导了细胞凋亡,显著降低了ROCK-I和ROCK-II的表达[5]。Fasudil (HA-1077) HCl(0.04、0.2、1μg/mL)预处理中性粒细胞和人肺微血管内皮细胞(HPMECs)建立的共培养系统30min,减少了中性粒细胞跨内皮细胞迁移,抑制了中性粒细胞内皮趋化性[6]。Fasudil (HA-1077) HCl(100μM)处理大鼠肝星状细胞和人肝星状细胞来源的TWNT-4细胞,抑制了细胞伸展、应力纤维的形成和α-SMA的表达,刺激基质金属蛋白酶-1(MMP-1)的产生和转录,并增强胶原酶活性[7]

在体内,Fasudil (HA-1077) HCl(10mg/kg)通过静脉注射治疗心脏缺血/再灌注损伤后的小鼠,抑制了c-Jun氨基末端激酶(JNK)介导的凋亡诱导因子(AIF)转位,减少了缺血再灌注时心肌细胞凋亡[8]

实验参考方法

Cell experiment [1]:

Cell lines

5637 cells、UM-UC-3 cells

Preparation Method

5637 cells and UM-UC-3 cells (5×104/well) were seeded into 96-well plates in serum-containing medium and were allowed to attach for 24h. Then the medium was removed and replaced with new medium containing 0, 1, 10, 30μM of Fasudil (HA-1077) HCl. After being cultured for 72h, the cells were incubated with 50μL of MTT(5mg/mL) for 1h. The formazan product was dissolved in 100 mL of DMSO and its absorbance was measured at a wavelength of 630nm in a microplate reader. Proliferation of 5637 cells and UM-UC-3 cells was also assessed by quantitative ELISA.

Reaction Conditions

0, 1, 10, 30μM; 72h

Applications

Fasudil (HA-1077) HCl inhibits the proliferation of 5637 cells and UM-UC-3 cells in a dose-dependent manner.

Animal experiment [2]:

Animal models

Female Wistar rats

Preparation Method

Five experimental groups were studied. 1.sham operation. (n=30); 2.left anterior descending branch(LAD) was occluded for 30 min and reperfused for 180min plus administration of normal saline(NS)[1ml normal saline i.v. 1h before operation] (n=18); 3.LAD was occluded for 30min and reperfused for 180min plus administration of Fasudil (HA-1077) HCl, inhibitor of Rho-kinase[10mg/kg i.v. 1h before operation. Fasudil (HA-1077) HCl was dissolved in 1ml normal saline] (n=18); 4.LAD was occluded for 30min and reperfused for 180min plus administration of SP600125, inhibitor of JNK[6mg/kg i.p. 2h before operation. SP600125 was dissolved in 100µl DMSO] (n=12); 5.LAD was occluded for 30min and reperfused for 180min plus administration of DMSO[100µl DMSO i.p. 2h before operation.] (n=12).

Dosage form

10mg/kg; i.v.

Applications

Fasudil (HA-1077) HCl reduced cell apoptosis in I/R in vivo via suppression of c-Jun N-terminal kinase(JNK)-mediated apoptosis-inducing factor(AIF) translocation.

References:
[1]Abe H, Kamai T, Hayashi K, et al. The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells[J]. BMC cancer, 2014, 14: 1-12.
[2]Zhang J, Li X X, Bian H J, et al. Inhibition of the activity of Rho-kinase reduces cardiomyocyte apoptosis in heart ischemia/reperfusion via suppressing JNK-mediated AIF translocation[J]. Clinica Chimica Acta, 2009, 401(1-2): 76-80.

化学性质

Cas No. 105628-07-7 SDF
别名 盐酸法舒地尔; HA-1077 Hydrochloride; AT-877 Hydrochloride
化学名 5-(1,4-diazepan-1-ylsulfonyl)isoquinoline;hydrochloride
Canonical SMILES C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3.Cl
分子式 C14H17N3O2S.HCl 分子量 327.83
溶解度 ≥ 16.4mg/mL in DMSO, ≥ 4.81 mg/mL in EtOH with ultrasonic, ≥ 50 mg/mL in Water 储存条件 Store at 4°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 3.0504 mL 15.2518 mL 30.5036 mL
5 mM 610.1 μL 3.0504 mL 6.1007 mL
10 mM 305 μL 1.5252 mL 3.0504 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置

产品文档

Quality Control & SDS

View current batch: